Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in BIOCRYST PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 1.3M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $12.4M as of 2026-Q1. The position was decreased (-48.8% shares). BCRX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$12.4M
Current Shares
1.3M
Total Value Change
+$11.9M
Total Shares Change
+1.2M
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 1.3M |
-48.8% |
| $12.4M |
| 0.0% |
| $8.69 |
0 |
| 2025-Q4 | Increased | 2.5M | +21.4% | $19.8M | 0.0% | $7.66 | 34 |
| 2025-Q3 | Increased | 2.1M | +43.8% | $15.9M | 0.0% | $7.55 | 38 |
| 2025-Q2 | Increased | 1.5M | +1059.7% | $13.1M | 0.0% | $9.36 | 45 |
| 2025-Q1 | Decreased | 125,627 | -36.0% | $942,202 | 0.0% | $7.86 | 0 |
| 2024-Q4 | Decreased | 196,225 | -60.5% | $1.5M | 0.0% | $7.53 | 0 |
| 2024-Q3 | Increased | 496,784 | +472.0% | $3.8M | 0.0% | $7.62 | 43 |
| 2024-Q2 | Decreased | 86,846 | -48.2% | $536,708 | 0.0% | $6.18 | 0 |